Biomea Fusion Stock Alpha and Beta Analysis
| BMEA Stock | USD 1.32 0.04 3.13% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biomea Fusion. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biomea Fusion over a specified time horizon. Remember, high Biomea Fusion's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biomea Fusion's market risk premium analysis include:
Beta 1.42 | Alpha 0.0971 | Risk 5.43 | Sharpe Ratio 0.11 | Expected Return 0.6 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Biomea Fusion Analysis, Biomea Fusion Valuation, Biomea Fusion Correlation, Biomea Fusion Hype Analysis, Biomea Fusion Volatility, Biomea Fusion Price History and analyze Biomea Fusion Performance. Biomea Fusion Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biomea Fusion market risk premium is the additional return an investor will receive from holding Biomea Fusion long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biomea Fusion. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biomea Fusion's performance over market.| α | 0.1 | β | 1.42 |
Biomea Fusion expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biomea Fusion's Buy-and-hold return. Our buy-and-hold chart shows how Biomea Fusion performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Biomea Fusion Market Price Analysis
Market price analysis indicators help investors to evaluate how Biomea Fusion stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biomea Fusion shares will generate the highest return on investment. By understating and applying Biomea Fusion stock market price indicators, traders can identify Biomea Fusion position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Tanh Of Price Series | ||
| Price Floor Movement | ||
| Plus Directional Indicator | ||
| Rate of change | ||
| Simple Moving Average | ||
| Exponential Moving Average | ||
| Tristar Pattern | ||
| Harami Pattern |
Biomea Fusion Return and Market Media
The median price of Biomea Fusion for the period between Sat, Nov 22, 2025 and Fri, Feb 20, 2026 is 1.29 with a coefficient of variation of 11.41. The daily time series for the period is distributed with a sample standard deviation of 0.14, arithmetic mean of 1.27, and mean deviation of 0.11. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Averill Julianne of 241177 shares of Biomea Fusion at 1.82 subject to Rule 16b-3 | 11/26/2025 |
2 | Acquisition by Erdtmann Rainer M of 40000 shares of Biomea Fusion at 1.1013 subject to Rule 16b-3 | 11/28/2025 |
3 | Acquisition by Michael Hitchcock of 100000 shares of Biomea Fusion at 0.9918 subject to Rule 16b-3 | 12/02/2025 |
4 | Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025 | 12/09/2025 |
5 | Interim CEO Director of Biomea Fusion Michael J. Hitchcock Buys 667 percent More Shares | 12/11/2025 |
6 | Top Executive Makes Bold Move with Major Stock Purchase in Biomea Fusion - TipRanks | 12/15/2025 |
7 | Published on 2026-01-13 190412 - moha.gov.vn | 01/13/2026 |
8 | Biomea Fusion Research Coverage Started at Rodman Renshaw | 01/16/2026 |
About Biomea Fusion Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biomea or other stocks. Alpha measures the amount that position in Biomea Fusion has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 7.84 | 3.15 | 3.63 | 3.44 | Net Debt To EBITDA | 1.34 | 0.35 | 0.4 | 0.38 |
Biomea Fusion Upcoming Company Events
As portrayed in its financial statements, the presentation of Biomea Fusion's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomea Fusion's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biomea Fusion's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biomea Fusion. Please utilize our Beneish M Score to check the likelihood of Biomea Fusion's management manipulating its earnings.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Biomea Fusion
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Biomea Fusion Analysis, Biomea Fusion Valuation, Biomea Fusion Correlation, Biomea Fusion Hype Analysis, Biomea Fusion Volatility, Biomea Fusion Price History and analyze Biomea Fusion Performance. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Biomea Fusion technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.